BTK and Bruton-type agammaglobulinemia: To explore the potential of using LHEs as gene modification tools for therapy of XLA, we selected a single base pair mutation within Exon 2 of the murine Btk gene as target site (this mutation is found in the XID mouse, a murine model of human XLA) (19,20).